“Feasible and effective administration of Bortezomib with Rituximab in children with relapsed/resistant B-cell precursor acute lymphoblastic leukemia (BCP-ALL): A step toward the first line”-Reference-Cited by-同舟云学术

“Feasible and effective administration of Bortezomib with Rituximab in children with relapsed/resistant B-cell precursor acute lymphoblastic leukemia (BCP-ALL): A step toward the first line”

Published:2019-09-14 Issue:7 Volume:36 Page:438-444
ISSN:0888-0018
Container-title:Pediatric Hematology and Oncology
language:en
Short-container-title:Pediatric Hematology and Oncology

Author:

Lo Nigro Luca¹²,Pulvirenti Giulio³,Cannata Emanuela¹,Bonaccorso Paola²,Andriano Nellina²,Russo Giovanna¹³

Affiliation:

1. Center of Pediatric Hematology Oncology, Azienda Policlinico OVE, Catania, Italy;

2. Center of Pediatric Hematology Oncology, Azienda Policlinico OVE, Cytogenetic, Cytofluorimetric, Molecular Biology Laboratory, Catania, Italy;

3. Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy

Publisher

Informa UK Limited

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

https://www.tandfonline.com/doi/pdf/10.1080/08880018.2019.1658834

Reference23 articles.

1. Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration

2. Cancer in childhood, adolescence, and young adults: a population-based study of changes in risk of cancer death during four decades in Norway

3. Childhood relapsed acute lymphoblastic leukemia: Biology and recent treatment progress

4. Pre- and post-transplant minimal residual disease predicts relapse occurrence in children with acute lymphoblastic leukaemia

5. Genomic Analysis of the Clonal Origins of Relapsed Acute Lymphoblastic Leukemia

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Low‐dose venetoclax, bortezomib, inotuzumab, rituximab, and dexamethasone (LoVe‐BIRD) in a child with relapsed/refractory B‐cell acute lymphoblastic leukemia with TP53 mutation;Pediatric Blood & Cancer;2024-07-02

2. Outcomes of adolescents with acute lymphoblastic leukaemia;Hong Kong Medical Journal;2022-06-13

3. Bortezomib/methotrexate;Reactions Weekly;2020-01

4. Bortezomib‐based four‐drug induction does induce a response in advanced relapsed ALL but cure remains elusive;Pediatric Blood & Cancer;2019-12-09